SERA-SCANDIA A/S: Financial statements 2016
CVR: 14605185
Source: annual report 2016, Danish Business Authority
01/04/2015 – 31/03/2016
SERA-SCANDIA A/S (CVR 14605185) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 96,048 and a net result of DKK 2,867,073 compared with DKK -3,721,848 the year before. That is an increase of 18.8% compared with the year before. The profit margin was 2,985%. Equity in the 2016 report amounted to DKK 31,825,680. The solvency ratio was 33.1%.
- Revenue
- DKK 96,048
- Gross Profit
- DKK -18,879
- Profit/Loss
- DKK 2,867,073
- Equity
- DKK 31,825,680
- Total Assets
- DKK 96,282,003
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 96K | -19K | 2.9M | 31.8M | - |
| 2015 | 81K | -18K | -3.7M | 29M | - |
| 2014 | 73K | 52K | -3.5M | 32.7M | - |
| 2013 | 0 | 0 | -8.8M | 36.2M | - |
Official annual report
Find more companies like SERA-SCANDIA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout SERA-SCANDIA A/S
SERA-SCANDIA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1990. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SERA-SCANDIA ApS and VICH 2604 ApS. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Christian Lykkehus Sørensen and Nicolas Bødtker Nielsen. The company is owned by Danbiotech Inc.. The company has 16 employees (2026). In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. Equity in the 2025 report amounted to DKK 272,104,000.